Atara Biotherapeutics (ATRA) Non Operating Interest Expenses (2022 - 2026)
Atara Biotherapeutics' Non Operating Interest Expenses was $191,000 in Q2 2026, down 80.3% from $972,000 a year earlier and down 77.0% from the prior quarter.
Atara Biotherapeutics (ATRA) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atara Biotherapeutics' Non Operating Interest Expenses was $2.82 million through Jun 30, 2026, down 32.6% year-over-year; for FY2025, it came in at $3.79 million, down 17.8% from FY2024.
- Non Operating Interest Expenses shows a three-year compound annual growth rate of 116.6% (FY2022 to FY2025).
- In earlier years, Non Operating Interest Expenses was $4.62 million in FY2024 (-12.7%), $5.29 million in FY2023 and $373,000 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Non Operating Interest Expenses since Q4 2022.
- Compared with a year earlier, Non Operating Interest Expenses has declined for ten straight quarters, with an average decline of 24.7% over the last eight quarters.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 968.2%); the worst was Q2 2026 (a decline of 80.3%).
- Per Business Quant data, ATRA's Non Operating Interest Expenses in the three quarters before Q2 2026 was $830,000 (Q1 2026), $894,000 (Q4 2025) and $909,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 191,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191,000.00 |
| Mar 31, 2026 | 830,000.00 |
| Dec 31, 2025 | 894,000.00 |
| Sep 30, 2025 | 909,000.00 |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | 4,000.00 |
Atara Biotherapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();